Literature DB >> 15346853

A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

David S Bayard1, Roger W Jelliffe.   

Abstract

This paper considers the updating of Bayesian posterior densities for pharmacokinetic models associated with patients having changing parameter values. For estimation purposes it is proposed to use the Interacting Multiple Model (IMM) estimation algorithm, which is currently a popular algorithm in the aerospace community for tracking maneuvering targets. The IMM algorithm is described, and compared to the multiple model (MM) and Maximum A-Posteriori (MAP) Bayesian estimation methods, which are presently used for posterior updating when pharmacokinetic parameters do not change. Both the MM and MAP Bayesian estimation methods are used in their sequential forms, to facilitate tracking of changing parameters. Results indicate that the IMM algorithm is well suited for tracking time-varying pharmacokinetic parameters in acutely ill and unstable patients, incurring only about half of the integrated error compared to the sequential MM and MAP methods on the same example.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15346853     DOI: 10.1023/b:jopa.0000029490.76908.0c

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  3 in total

1.  Design of dosage regimens: a multiple model stochastic control approach.

Authors:  D S Bayard; M H Milman; A Schumitzky
Journal:  Int J Biomed Comput       Date:  1994-06

2.  Preliminary results of three methods for population pharmacokinetic analysis (NONMEM, NPML, NPEM) of amikacin in geriatric and general medicine patients.

Authors:  P Maire; X Barbaut; P Girard; A Mallet; R W Jelliffe; T Berod
Journal:  Int J Biomed Comput       Date:  1994-06

3.  Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen.

Authors:  Roger Jelliffe
Journal:  Am J Nephrol       Date:  2002 Jul-Aug       Impact factor: 3.754

  3 in total
  19 in total

1.  Sequential updating of a new dynamic pharmacokinetic model for caffeine in premature neonates.

Authors:  Sandrine Micallef; Billy Amzal; Véronique Bach; Karen Chardon; Pierre Tourneux; Frédéric Y Bois
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

2.  Evaluation and comparison of simple multiple model, richer data multiple model, and sequential interacting multiple model (IMM) Bayesian analyses of gentamicin and vancomycin data collected from patients undergoing cardiothoracic surgery.

Authors:  Iona Macdonald; Christine E Staatz; Roger W Jelliffe; Alison H Thomson
Journal:  Ther Drug Monit       Date:  2008-02       Impact factor: 3.681

3.  Are vancomycin trough concentrations adequate for optimal dosing?

Authors:  Michael N Neely; Gilmer Youn; Brenda Jones; Roger W Jelliffe; George L Drusano; Keith A Rodvold; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

4.  Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.

Authors:  Roger Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447

5.  Semiparametric mixed-effects analysis of PK/PD models using differential equations.

Authors:  Yi Wang; Kent M Eskridge; Shunpu Zhang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-10       Impact factor: 2.745

Review 6.  Optimising antimicrobial therapy through the use of Bayesian dosing programs.

Authors:  M L Avent; B A Rogers
Journal:  Int J Clin Pharm       Date:  2019-08-07

7.  Author's Reply to Proost: "Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients".

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

8.  Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".

Authors:  Roger W Jelliffe
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

9.  Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.

Authors:  Michael N Neely; Lauren Kato; Gilmer Youn; Lironn Kraler; David Bayard; Michael van Guilder; Alan Schumitzky; Walter Yamada; Brenda Jones; Emi Minejima
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

10.  Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Authors:  Christoffer W Tornøe; Rune V Overgaard; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.